Rennaï Presents the Re|edït, the first-ever expert-led series. Chapter 1: GLP-1, Skin Health, and the Future of Aesthetics
Join Dr. Mirko Gilardino and Dr. Andreas Nikolis for an intimate discussion on how GLP-1 weight-loss medications are redefining health and beauty. From appetite suppression and metabolic benefits to facial aesthetics and regenerative treatments, the panel explored the science, challenges, and opportunities shaping this rapidly evolving space.
The Science Behind GLP-1 Medications
Originally developed for diabetes, GLP-1 medications have quickly become a cultural phenomenon in weight management. Their primary mechanism is simple but powerful: they suppress appetite, helping patients reduce caloric intake and achieve meaningful weight loss. Beyond weight management, the panel highlighted a growing body of research pointing to secondary benefits — from metabolic and anti-inflammatory effects to potential neuroprotective properties. As newer generations of GLP1’s are developed, they will increasingly be used as a strategy for patients who are looking to harness these broader health benefits, in addition to weight control.
“GLP-1 medications affect nearly every organ in the body, which is why researchers are exploring benefits far beyond weight loss.”
Rapid Weight Loss and Its Aesthetic Implications
While the health advantages of GLP-1 therapy are clear, rapid weight loss can create aesthetic challenges, especially in the face. Facial fat provides structural support, and when it diminishes faster than the skin can adapt, the result may be hollowing, laxity, or early signs of aging.
“The faster the weight loss, the harder it is for the skin to keep up,” Dr. Gilardino noted. “With GLP-1 medications, people may lose a pound a week or more, which accelerates the process beyond what the skin can easily adapt to.”
This phenomenon mirrors what has been observed following bariatric surgery, underscoring the importance of understanding how metabolism and aesthetics intersect.
Collagen, Fat, and Facial Health
The panel also explored the connection between GLP-1 therapy and collagen signaling. Even small doses can subtly affect facial fat, highlighting the sensitivity of certain tissues to metabolic changes.
“You’re losing the signal that tells your skin to produce collagen,” explained Dr. Gilardino. “Even patients who aren’t losing weight may notice changes in facial fat and skin quality.”
These insights emphasize the need for proactive strategies to maintain facial health alongside weight loss.
Regenerative Treatments: Beyond Fillers
A highlight of the discussion was the role of biostimulatory injectables. Unlike traditional fillers, which add volume, biostimulators focus on enhancing the skin’s natural quality by stimulating collagen production, improving elasticity, and subtly lifting the skin without obvious changes.
“The best injectable is undetectable,” said Dr. Andreas Nikolis. “Treatments should enhance natural features, not announce themselves.”
For patients navigating facial changes from rapid weight loss, biostimulators provide a non-surgical alternative to restore skin health and resilience.
The Future of Aesthetics in the GLP-1 Era
GLP-1 medications represent a medical breakthrough, but their aesthetic implications require nuanced care and planning. The Re|Edït panel emphasized balance: understanding the science, setting realistic expectations, and combining metabolic health strategies with modern aesthetic and regenerative treatments. As the use of GLP-1 therapies grows, the intersection between weight management and aesthetic medicine will become increasingly important. Early consultation with one of our MDs, preferably before the weight loss journey has begun, will help to identify skin treatments to optimize the elasticity, health and appearance of the skin on the face and body. The panel’s key takeaway: knowledge, preparation, and tailored skin interventions are the best tools for looking—and feeling—your best throughout the weight transformation.